JOURNAL FOR IMMUNOTHERAPY OF CANCER Journal

publication venue for

Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study. 10. 2022
Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial. 7. 2019
Nature of coexisting thyroid autoimmune disease determines success or failure of tumor immunity in thyroid cancer. 7. 2019

category

IMMUNOLOGY Category
ONCOLOGY Category

International Standard Serial Number (ISSN)

2051-1426

Electronic International Standard Serial Number (EISSN)

2051-1426

journal abbreviation

J IMMUNOTHER CANCER